← Back to headlines
CV Sciences Details CMS Program for Hemp Products, Targets Positive Cash Flow
CV Sciences has outlined a CMS program that allows up to $500 annually in hemp-derived products, as the company aims to achieve positive cash flow in the second half of 2026.
14 May, 22:51 — 14 May, 22:51
Sources
Showing 1 of 1 sources
Related Stories
Cornerstone Funds Declare Monthly Dividends and Announce 2026/2027 Distributions
3h ago
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
4h ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
6h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
7h ago